The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Twelve injured by falling debris in Abu Dhabi's Ajban area
40 million take part in Arab Reading Challenge, says H.H. Sheikh Mohammed
UAE intercepts 22 missiles and 47 drones on Friday
Fire breaks out at Abu Dhabi gas facility due to fallen debris
Dubai Police warns against dangerous driving habits
